{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T13:40:21Z","timestamp":1683380421612},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1990,7,1]],"date-time":"1990-07-01T00:00:00Z","timestamp":646790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1990,7,1]],"date-time":"1990-07-01T00:00:00Z","timestamp":646790400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[1990,7]]},"DOI":"10.1007\/bf02274840","type":"journal-article","created":{"date-parts":[[2006,2,14]],"date-time":"2006-02-14T05:14:54Z","timestamp":1139894094000},"page":"153-158","source":"Crossref","is-referenced-by-count":2,"title":["The effect of gold treatment on monocyte interleukin-1 production in rheumatoid arthritis"],"prefix":"10.1007","volume":"10","author":[{"given":"V. A.","family":"Danis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. J.","family":"Kulesz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. E.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. S.","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. M.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF02274840_CR1","doi-asserted-by":"crossref","first-page":"39","DOI":"10.3109\/03009748809102951","volume":"76","author":"M Feldmann","year":"1988","unstructured":"Feldmann M, Kissonerghis AM, Buchan G et al (1988) Role of HLA class II and cytokine expression in rheumatoid arthritis. Scand J Rheumatol [Suppl] 76: 39\u201346","journal-title":"Scand J Rheumatol"},{"key":"BF02274840_CR2","first-page":"1623","volume":"15","author":"N Yamagata","year":"1988","unstructured":"Yamagata N, Kobayashi K, Kasama T et al (1988) Multiple cytokine activities and loss of interleukin-2 inhibitor in synovial fluids of patients with rheumatoid arthritis. J Rheumatol 15: 1623\u20131627","journal-title":"J Rheumatol"},{"key":"BF02274840_CR3","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/art.1780310404","volume":"31","author":"N Miyasaka","year":"1988","unstructured":"Miyasaka N, Sato K, Goto M et al (1988) Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. Arthritis Rheum 31: 480\u2013486","journal-title":"Arthritis Rheum"},{"key":"BF02274840_CR4","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S0140-6736(88)90185-7","volume":"II","author":"JA Eastgate","year":"1988","unstructured":"Eastgate JA, Symons JA, Wood NC, Grinlinton FM, Di Giovine FS, Duff GW (1988) Correlation of plasma interleukin 1 levels with disease activity in rheumatoid arthritis. Lancet II: 706\u2013709","journal-title":"Lancet"},{"key":"BF02274840_CR5","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1172\/JCI113135","volume":"80","author":"M Goto","year":"1987","unstructured":"Goto M, Sasano M, Yamanaka H et al (1987) Spontaneous production of an interleukin-1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest 80: 786\u2013796","journal-title":"J Clin Invest"},{"issue":"1","key":"BF02274840_CR6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/rheumatology\/XXIV.suppl_1.191","volume":"24","author":"AME Nouri","year":"1985","unstructured":"Nouri AME, Panayi GS, Goodman SM, Waugh APW (1985) Cytokines in rheumatoid arthritis: production of IL-1. Br J Rheumatol [Suppl 1] 24: 191\u2013196","journal-title":"Br J Rheumatol"},{"key":"BF02274840_CR7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-3083.1986.tb01977.x","volume":"23","author":"K Waalen","year":"1986","unstructured":"Waalen K, Duff GW, F\u00f8rre \u00d8, Dickens E, Kvarnes L, Nuki G (1986) Interleukin-1 activity produced by human rheumatoid and normal dendritic cells. Scand J Immunol 23: 365\u2013371","journal-title":"Scand J Immunol"},{"key":"BF02274840_CR8","first-page":"293","volume":"65","author":"A Shore","year":"1986","unstructured":"Shore A, Jaglal S, Keystone EC (1986) Enhanced interleukin-1 generation by monocytes in vitro is temporally linked to an early event in the onset or exacerbation of rheumatoid arthritis. Clin Exp Immunol 65: 293\u2013302","journal-title":"Clin Exp Immunol"},{"key":"BF02274840_CR9","first-page":"33","volume":"14","author":"VA Danis","year":"1987","unstructured":"Danis VA, March LM, Nelson DS, Brooks PM (1987) Interleukin-1 secrection by peripheral blood monocytes and synovial macrophages from patients with rheumatoid arthritis. J Rheumatol 14: 33\u201339","journal-title":"J Rheumatol"},{"key":"BF02274840_CR10","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/0049-0172(85)90037-X","volume":"14","author":"WF Kean","year":"1985","unstructured":"Kean WF, Forestier F, Kassam Y, Buchanan WW, Rooney PJ (1985) The history of gold therapy in rheumatoid disease. Semin Arthritis Rheum 14: 180\u2013186","journal-title":"Semin Arthritis Rheum"},{"issue":"1","key":"BF02274840_CR11","first-page":"55","volume":"27","author":"RD Situnayake","year":"1988","unstructured":"Situnayake RD (1988) Can disease modifying drugs influence outcome in rheumatoid arthritis? Br J Rheumatol [Suppl 1] 27: 55\u201365","journal-title":"Br J Rheumatol"},{"key":"BF02274840_CR12","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1093\/rheumatology\/23.1.6","volume":"23","author":"GJ Alexander","year":"1984","unstructured":"Alexander GJ, Bacon PA, Cavalcanti F, Blake DR, Hall ND (1984) Low density lymphocytes: their relationship to disease activity and to antirheumatic therapy. Br J Rheumatol 23: 6\u201314","journal-title":"Br J Rheumatol"},{"key":"BF02274840_CR13","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1136\/ard.40.3.254","volume":"40","author":"J Highton","year":"1981","unstructured":"Highton J, Panayi GS, Shepherd P, Griffin J, Gibson T (1981) Changes in immune function in patients with rheumatoid arthritis following treatment with sodium aurothiomalate. Ann Rheum Dis 40: 254\u2013262","journal-title":"Ann Rheum Dis"},{"key":"BF02274840_CR14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF01977265","volume":"19","author":"ML Barrett","year":"1986","unstructured":"Barrett ML, Lewis GP (1986) Unique properties of auranofin as a potential anti-rheumatic drug. Agents Actions 19: 109\u2013115","journal-title":"Agents Actions"},{"key":"BF02274840_CR15","first-page":"1123","volume":"14","author":"ML Drakes","year":"1987","unstructured":"Drakes ML, Harth M, Galsworthy SB, McCain GA (1987) Effects of gold on the production of and response to human interleukin-1. J Rheumatol 14: 1123\u20131127","journal-title":"J Rheumatol"},{"key":"BF02274840_CR16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1365-2249.1990.tb08092.x","volume":"79","author":"VA Danis","year":"1990","unstructured":"Danis VA, Kulesz AJ, Nelson DS, Brooks PM (1990) The effect of gold sodium thiomalate and auranofin on lipopolysaccharide-induced interleukin-1 production by blood monocytes in vitro: variation in normal subjects and patients with arthritis. Clin Exp Immunol 79: 335\u2013340","journal-title":"Clin Exp Immunol"},{"key":"BF02274840_CR17","first-page":"175","volume":"9","author":"MW Ropes","year":"1958","unstructured":"Ropes MW, Bennett EA, Cobb S, Jacox R, Jessar R (1958) Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 9: 175\u2013176","journal-title":"Bull Rheum Dis"},{"key":"BF02274840_CR18","first-page":"789","volume":"9","author":"JF Fries","year":"1982","unstructured":"Fries JF, Spitz PW, Young DY (1982) The dimensions of health outcomes: The Health Assessment Questionnaire, disability and pain scales. J Rheumatol 9: 789\u2013793","journal-title":"J Rheumatol"},{"key":"BF02274840_CR19","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2249.1990.tb03306.x","volume":"80","author":"VA Danis","year":"1990","unstructured":"Danis VA, Kulesz AJ, Nelson DS, Brooks PM (1990) Cytokine regulation of human monocyte interleukin-1 (IL-1) productionin vitro. Enhancement of IL-1 production by interferon\u03b3, tumour necrosis factor\u03b1, IL-2 and IL-1, and inhibition by interferon\u03b1. Clin Exp Immunol 80: 435\u2013443","journal-title":"Clin Exp Immunol"},{"key":"BF02274840_CR20","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.4049\/jimmunol.138.6.1813","volume":"138","author":"TR Mosmann","year":"1987","unstructured":"Mosmann TR, Yokota T, Kastelein R, Zurawski SM, Arai N, Takebe Y (1987) Species specificity of T cell stimulating activities of IL-2 and BSF-1 (IL-4): comparison of normal and recombinant, mouse and human IL-2 and BSF-1 (IL-4). J Immunol 138: 1813\u20131816","journal-title":"J Immunol"},{"key":"BF02274840_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0090-1229(82)90205-7","volume":"25","author":"M Seitz","year":"1982","unstructured":"Seitz M, Deiman W, Gram N, Hunstein W, Gemsa D (1982) Characterisation of blood mononuclear cells of rheumatoid arthritis patients. I depressed lymphocyte proliferation and enhanced prostanoid release from monocytes. Clin Immunol Immunopathol 25: 405\u2013416","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02274840_CR22","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/0090-1229(88)90130-4","volume":"49","author":"S Endres","year":"1988","unstructured":"Endres S, Ghorbani R, Lonnemann G, Van Der Meer JWM, Dinarello CA (1988) Measurement of immunoreactive interleukin-1 beta from human mononuclear cells: optimization of recovery, intrasubject consistency, and comparison with interleukin-1 alpha and tumor necrosis factor. Clin Immunol Immunopathol 49: 424\u2013438","journal-title":"Clin Immunol Immunopathol"},{"key":"BF02274840_CR23","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/j.1365-3083.1988.tb02404.x","volume":"27","author":"J M\u00f8lvig","year":"1988","unstructured":"M\u00f8lvig J, Baek L, Christensen P et al (1988) Endotoxin-stimulated human monocyte secretion of interleukin 1, tumour necrosis factor alpha, and prostaglandin E2 shows stable inter individual differences. Scand J Immunol 27: 705\u2013716","journal-title":"Scand J Immunol"},{"key":"BF02274840_CR24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4049\/jimmunol.143.3.913","volume":"143","author":"P Santamaria","year":"1989","unstructured":"Santamaria P, Gehrz RC, Bryan MK, Barbosa JJ (1989) Involvement of class II MHC molecules in the LPS-induction of IL-1\/TNF secretions by human monocytes. Quantitative differences at the polymorphic level. J Immunol 143: 913\u2013922","journal-title":"J Immunol"},{"key":"BF02274840_CR25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/03009748709165271","volume":"16","author":"M Harth","year":"1987","unstructured":"Harth M, Davis P, Thompson JM, Menard H, Beaudet F (1987) Comparison between sodium aurothiomalate and auranofin in rheumatoid arthritis. Results of a two year open randomized study. Scand J Rheumatol 16: 177\u2013184","journal-title":"Scand J Rheumatol"},{"key":"BF02274840_CR26","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/03009748709102924","volume":"16","author":"EA Kay","year":"1987","unstructured":"Kay EA, Jayson MI (1987) Risk factors that may influence development of side effects of gold sodium thiomalate. Scand J Rheumatol 16: 241\u2013245","journal-title":"Scand J Rheumatol"},{"key":"BF02274840_CR27","first-page":"111","volume":"5","author":"EM Veys","year":"1987","unstructured":"Veys EM, Mielants H, Verbruggen G (1987) Gold salts, levamisole, and d-penicillamine as first choice slow-acting antirheumatic drugs in rheumatoid arthritis \u2014 a long term follow up study. Clin Exp Rheumatol 5: 111\u2013116","journal-title":"Clin Exp Rheumatol"},{"key":"BF02274840_CR28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/art.1780310102","volume":"31","author":"HJ Williams","year":"1988","unstructured":"Williams HJ, Dahl SL, Ward JR et al (1988) One year experience in patients treated with auranofin following completion of a parallel, controlled trial comparing auranofin, gold sodium thiomalate and placebo. Arthritis Rheum 31: 9\u201314","journal-title":"Arthritis Rheum"},{"issue":"2","key":"BF02274840_CR29","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/BF02203383","volume":"6","author":"KK Bandilla","year":"1987","unstructured":"Bandilla KK, Missler B (1987) Long-term results of auranofin therapy. Clin Rheumatol [Suppl 2] 6: 35\u201342","journal-title":"Clin Rheumatol"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02274840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF02274840\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02274840","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF02274840.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,6]],"date-time":"2023-05-06T13:12:32Z","timestamp":1683378752000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF02274840"}},"subtitle":["A prospective study"],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["BF02274840"],"URL":"https:\/\/doi.org\/10.1007\/bf02274840","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}